Androgen resistance due to mutation of the androgen receptor

L Pinsky1, M Trifiro, M Kaufman

  • 1Lady Davis Institute, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec.

Insights

Mutations in the androgen receptor (AR) gene cause a wide range of androgen resistance conditions. Identifying these AR gene alterations aids in diagnosis and understanding AR

Area of Science:

  • Molecular endocrinology
  • Genetics
  • Human physiology

Background:

  • The androgen receptor (AR) is a key DNA-binding protein regulating gene expression in response to androgens.
  • Mutations in the AR gene lead to a spectrum of androgen resistance disorders, affecting sexual development and reproductive health.
  • Understanding AR function is crucial for diagnosing and managing conditions related to androgen insensitivity.

Purpose of the Study:

  • To identify pathogenic alterations in the androgen receptor (AR) gene in families with androgen resistance.
  • To correlate AR genotype with clinical phenotypes and receptor activity in patients.
  • To contribute to a structure-function map of the AR and related steroid receptors.

Main Methods:

  • Genetic analysis of the AR gene in 38 families with androgen resistance.
  • Assessment of androgen-binding activity in genital skin fibroblasts.
  • Correlation of identified AR gene mutations with clinical presentation and receptor phenotypes.

Main Results:

  • Identified 32 pathogenic or putatively pathogenic alterations in the AR gene across 38 families.
  • Most identified mutations were located within the AR's androgen-binding domain.
  • Findings enable heterozygote detection and prenatal diagnosis for relevant family members.

Conclusions:

  • Genetic variations in the androgen receptor (AR) gene are a primary cause of androgen resistance.
  • Detailed genotype-phenotype correlations enhance understanding of AR function and its role in disease.
  • This research facilitates improved diagnostic capabilities and genetic counseling for androgen resistance disorders.

Related Concept Videos

Mismatch Repair01:48

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.The Mutator Protein Family Plays a Key Role in DNA Mismatch RepairThe human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Gene Conversion02:08

Gene Conversion

Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...